[{"id":"06e8621c-f152-4896-9d55-aa46ab3bf070","acronym":"","url":"https://clinicaltrials.gov/study/NCT05357651","created_at":"2022-05-03T15:54:12.396Z","updated_at":"2024-07-02T16:35:14.826Z","phase":"Phase 1","brief_title":"A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma（Keyplus-001）","source_id_and_acronym":"NCT05357651","lead_sponsor":"L \u0026 L biopharma Co., Ltd., Shanghai China","biomarkers":" HAVCR2","pipe":"","alterations":" ","tags":["HAVCR2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e LB1410"],"overall_status":"Recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 08/12/2022","start_date":" 08/12/2022","primary_txt":" Primary completion: 12/30/2024","primary_completion_date":" 12/30/2024","study_txt":" Completion: 03/11/2025","study_completion_date":" 03/11/2025","last_update_posted":"2024-03-13"}]